Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

http://www.wikidata.org/entity/Q33750632

about

Nephrotoxic effects of common and emerging drugs of abuse.Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.Reversal of diabetic nephropathy by a ketogenic diet.Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.Endocannabinoid signaling at the periphery: 50 years after THC.Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.Modulating the endocannabinoid system in human health and disease--successes and failures Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats.Role of the endocannabinoid system in diabetes and diabetic complications.The podocyte as a target for therapies--new and old.Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.Cannabinoids and the Kidney: Effects in Health and Disease.Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.Role for cannabinoid receptors in human proximal tubular hypertrophy.Synthetic marijuana and acute kidney injury: an unforeseen association The endocannabinoid system in renal cells: regulation of Na(+) transport by CB1 receptors through distinct cell signalling pathways.Synthetic cannabinoids and acute kidney injury.Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.Relationship between G proteins coupled receptors and tight junctions.Synthetic cannabinoids in the kidneys.Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.Cannabinoid receptor 1 mediates high glucose-induced apoptosis via endoplasmic reticulum stress in primary cultured rat mesangial cells.

P2860

Q21558458-79463EB0-4393-4DA0-8B6A-0CCCD0E2D62C Q33655394-D16E789C-F022-4A79-867F-B49DF23D6DFF Q33816779-FDB40C0B-AA6E-415F-A17B-86D229874077 Q33886222-5BCDA776-59E9-45F5-B220-4E6E39CA8825 Q34290823-49B7C7CD-1E14-4E09-9E37-78BB513C0CD1 Q34752048-7B27445F-A0AC-4DC3-89C4-B368B669538A Q35179985-B55CCAD8-35CB-45BB-AF92-E832EB368C5F Q35572176-DFF0CDCD-902C-465F-BB9B-62CF31A6124B Q35766956-162F1C0D-4E57-4B78-AC65-D9F0E4536417 Q35951992-35F0408E-72D8-4BE0-9226-B06855774C54 Q36032332-6B42E957-3D2C-4561-A835-CFE67BAAB054 Q36159004-B00B4EF4-E403-440A-BA93-D44B667F7FFE Q36506869-59B10F81-A93A-48C8-BC81-E0CC529BBFEA Q36933683-34D945B3-9761-4C21-B362-5FC45A60BCDF Q37019804-6167BB9A-6BB2-4AAD-8E14-CC6E86D0CE27 Q37085532-B97A6EF9-D32A-45FE-830C-54F86AEC57D1 Q37951800-C7C72BCA-5D6F-4B9E-89A5-F6771D690ED3 Q38220272-D91AFA8F-53C1-451A-BBB6-8944E030A4AF Q38255902-E9AF7523-6FAA-4AE2-90E1-07F84B44782E Q38398867-F7753BF5-7FB3-4AE0-81BC-85F9989C296F Q38651395-31BCA8C9-5BA6-4BD4-A794-C008B5C45176 Q38924783-6B1B7809-DADD-436C-AC5D-A8A14307A7E3 Q39609590-F32E465D-91F1-4647-ACDC-13BF1829E4B4 Q39719706-19F015E3-BFED-4B8C-BC88-115F571BE379 Q41295964-D2F94DF2-9926-4A7F-A6FD-01E6C62E2D99 Q41766626-AA2914A2-476C-4B68-B499-78C5DD55EA74 Q41963239-EC604551-2074-46EC-99F1-2A663CD96B1F Q47445806-22F6B6D9-1CC8-4C39-B3E6-00DFBD4D37BC Q47874226-C87E9917-C52A-4C7E-B1B2-9BDC85ACBB3D Q47985501-EEE18467-7B95-4AB0-A69C-9993D79467A5 Q50116104-B2FF88DF-F7AC-4A6B-93B2-89E1492623C6 Q50878765-1218B90F-A11E-4297-97B3-5563C19AE9C1 Q51067641-AA2C3776-E9A0-4011-BA8D-A4C605CF9EEF Q51835187-76A036B1-B15F-4C4C-BA50-665A44D24093 Q52649284-49B0D89E-03CA-422F-9A7F-741EF0923CFE Q54387514-2F09BE10-C1C0-4988-A41E-2D9FE4D0147D

P2860

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

http://www.wikidata.org/entity/Q33750632

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.

@ast

Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.

@en

type

label

Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.

@ast

Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.

@en

prefLabel

Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.

@ast

Cannabinoid receptor 1 blockad ...... rimental diabetic nephropathy.

@en

P1433

Q33750632-E617BC70-03FF-4284-9CC8-638A45371D3C

P1476

Q33750632-99A92BBE-D4FC-4DC3-94E7-8955F63EF7B0

P2093

Q33750632-19DC3E72-3AAE-4773-87E5-2B89873A1A46

Q33750632-25D1751B-63B0-4263-BDE6-E475E347B7AC

Q33750632-3DC61450-AE28-4C3A-9CC5-4A9938986088

Q33750632-78ED51EF-2574-417B-9738-2204D5215515

Q33750632-9F7AC421-A2F3-4FA8-9506-546395C078CC

Q33750632-A30F4329-C6F2-4BD3-B0D9-49BEC3D91AFC

Q33750632-A97F3543-C37B-4A2E-A5A2-F52BEDCFB0A5

Q33750632-F7F2B86A-1730-4DCF-B485-B7AD5721DF7E

P2860

Q33750632-05B132EB-E125-4534-B91A-83ABE6AD80E5

Q33750632-077C1CC2-51B6-420B-B150-158D22CEF9C0

Q33750632-1259EF75-36B0-4D19-B85D-4435528CBC11

Q33750632-247045C7-3771-4CDE-8A17-E32AAAE791A3

Q33750632-2505F954-17E8-4E22-9726-7AC3CA95C642

Q33750632-29559A20-4D4C-46E4-9336-AF426108028B

Q33750632-30BA5AE5-6A47-40FC-9BCE-EA80A34DFA80

Q33750632-3600CF19-808B-4A23-9810-6952CFA432C9

Q33750632-3601078A-D612-437F-A50F-985B337690AA

Q33750632-3679550C-522D-4C75-A382-5A225493BA92

P304

Q33750632-1A284BF5-09A0-4030-88DE-0D4BBBA9BCA5

P31

Q33750632-C43D555A-F2A4-48D6-B7C0-7DBEBFA8064E

P356

Q33750632-2E059703-033D-41FE-8C96-759CEEF129C3

P407

Q33750632-BCBDA947-5125-4DC4-AD46-08065EA5E6B4

P433

Q33750632-3556BC7A-3270-4700-9387-1DF0C4A47677

P478

Q33750632-BB1563FB-CDFD-4E32-B7C2-E4802065109D

P50

Q33750632-57D80A39-47D4-4B13-A408-714B09708EBD

P577

Q33750632-041B8920-7B5B-4387-9460-34C96AE2F30B

P5875

Q33750632-C915A8AE-AB7E-4E90-ACDF-EC9582604F01

P698

Q33750632-50F9F3C8-BF6B-430B-91C7-EDC1CC22AB76

P921

Q33750632-0a951fa1-2346-4615-a01d-8bbb9cfce7de

Q33750632-9E156065-2A88-4A0B-AE37-AB6A56F399B4

Q33750632-AE7750A3-F36B-4935-9303-83B0F876AC67

P932

Q33750632-2560DB51-DF97-4DAF-B605-54B26C9B8B1D

P356

P1433

P1476

Cannabinoid receptor 1 blockad ...... erimental diabetic nephropathy

@en

P2093

Alessandro Corbelli

http://www.w3.org/2001/XMLSchema#string

Federica Barutta

http://www.w3.org/2001/XMLSchema#string

Gabriella Gruden

http://www.w3.org/2001/XMLSchema#string

Maria Pia Rastaldi

http://www.w3.org/2001/XMLSchema#string

Paolo Cavallo Perin

http://www.w3.org/2001/XMLSchema#string

Roberto Gambino

http://www.w3.org/2001/XMLSchema#string

Silvia Pinach

http://www.w3.org/2001/XMLSchema#string

Vincenzo Di Marzo

http://www.w3.org/2001/XMLSchema#string

P2860

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists

Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.

Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome.

Role of nephrin in renal disease including diabetic nephropathy.

Cell biology of the glomerular podocyte.

P304

1046-1054

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-1336

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Raffaella Mastrocola

P577

2010-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41000802

http://www.w3.org/2001/XMLSchema#string

P698

20068137

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

P932

2844813

http://www.w3.org/2001/XMLSchema#string